Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

LWP and lymphoma-related meetings and presentations
LWP and lymphoma-related meetings and presentations
by test
Lisbon 2018. #EBMT18. Tuesday 20 . March. . 2018...
Epstein-Barr Virus: Cancer and Immunosuppression
Epstein-Barr Virus: Cancer and Immunosuppression
by DynamicDiva
. . . Pathogenesis of EBV Infection. ...
Epstein-Barr Virus:
Epstein-Barr Virus:
by mitsue-stanley
Cancer and Immunosuppression. . . . Pathogenes...
Please note, these are the
Please note, these are the
by ryotheasy
actual. . video-recorded proceedings from the . l...
How often do
How often do
by pasty-toler
immunomodulators. and/or biologics cause lymphom...
Eastern Ophthalmic Pathology
Eastern Ophthalmic Pathology
by Savageheart
2018 Meeting – . Washington, DC. Diva R Salomão...
Autologous Stem Cell Transplantation
Autologous Stem Cell Transplantation
by kittie-lecroy
Present. . and. . Future. Mustafa CETIN. ,. ....
Flow Cytometry/ Bone Marrow Laboratory
Flow Cytometry/ Bone Marrow Laboratory
by adah
Department of Pathology and Laboratory Medicine. L...
Ro le of Stem Cell Transplant in Patients with Peripheral T-Cell
Ro le of Stem Cell Transplant in Patients with Peripheral T-Cell
by sylvia
Lymphoma and Response to Treatment Strategies . IN...
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation
by alida-meadow
Location of Centers Participating. in the CIBMTR ...
Post-autologous Transplant Therapy for Hodgkin Lymphoma
Post-autologous Transplant Therapy for Hodgkin Lymphoma
by sherrill-nordquist
Program Goals. cHL. Overview. cHL. Poor Prognosis...
Brentuximab
Brentuximab
by briana-ranney
. Vedotin. Should be the Second Line Regimen of...
Brentuximab Vedotin.
Brentuximab Vedotin.
by luanne-stotts
How and When Should it be Used in B and T cell Ly...
Should All Eligible Patients with Mantle Cell Lymphoma Be T
Should All Eligible Patients with Mantle Cell Lymphoma Be T
by ellena-manuel
Answer: No. Peter Martin, M.D.. The Charles, Lill...